Stay updated with breaking news from Initial Experience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SOLANA BEACH, Calif., June 01, 2024 -- ClearPoint Neuro, Inc. , a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announces full...
BHPian TheMbaCarGuy recently shared this with other enthusiasts.Purchase and Initial Experience of Exter SX AMT - 500 kms ownershipI was in the market to buy my first car - preferably an automatic.
GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings were presented during the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023, being held this week in San Diego, CA.
/PRNewswire/ -- GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced interim...
MELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces presentations featuring the Company's theranostic programs at the 36th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in Vienna from 9 - 13 September 2023. Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalTrials.gov Identifier: NCT03849118) will be presented in on oral session on Sunday 10 September. In addition, the co...